The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Nova Tina Susan since 2008.
The trader's CIK number is 1302605.
At the time of the last reporting, Nova Tina Susan was the Director of Arena Pharmaceuticals Inc. (stock ticker symbol ARNA).
Also see all insider trading activities at Arena Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ARNA | 0 | $0 | 17,300 | $1,175,310 | 17,300 | $274,499 |
| 2019 | ARNA | 0 | $0 | 1,200 | $55,183 | 1,200 | $48,120 |
| 2014 | ARNA | 0 | $0 | 35,000 | $217,770 | 35,000 | $179,725 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | GXDX | 0 | $0 | 0 | $0 | 279,491 | $2,044,476 |
| 2010 | GXDX | 0 | $0 | 76,824 | $2,576,035 | 76,824 | $76,340 |
| 2009 | GXDX | 0 | $0 | 111,109 | $3,373,905 | 111,109 | $50,180 |
| 2008 | GXDX | 0 | $0 | 118,212 | $3,014,406 | 117,542 | $95,209 |
1. Arena Pharmaceuticals Inc (ARNA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-08-26 | ARNA | Option Ex | 17,300 | 15.87 | 274,499 |
| 2020-08-26 | ARNA | Sale | 17,300 | 67.94 | 1,175,310 |
| 2019-03-07 | ARNA | Option Ex | 1,200 | 40.10 | 48,120 |
| 2019-03-07 | ARNA | Sale | 1,200 | 45.99 | 55,183 |
| 2014-04-14 | ARNA | Sale | 35,000 | 6.22 | 217,770 |
| 2014-04-14 | ARNA | Option Ex | 35,000 | 5.13 | 179,725 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-02-26 | GXDX | Option Ex | 279,491 | 7.32 | 2,044,476 |
| 2010-11-10 | GXDX | Sale | 1,624 | 17.68 | 28,710 |
| 2010-11-10 | GXDX | Option Ex | 1,624 | 9.50 | 15,428 |
| 2010-04-06 | GXDX | Sale | 20,900 | 36.45 | 761,867 |
| 2010-04-06 | GXDX | Option Ex | 20,900 | .81 | 16,929 |
| 2010-03-03 | GXDX | Option Ex | 16,700 | .81 | 13,527 |
| 2010-03-03 | GXDX | Sale | 16,700 | 31.90 | 532,746 |
| 2010-02-03 | GXDX | Option Ex | 16,700 | .81 | 13,527 |
| 2010-02-03 | GXDX | Sale | 16,700 | 31.13 | 519,854 |
| 2010-01-06 | GXDX | Option Ex | 20,900 | .81 | 16,929 |
| 2010-01-06 | GXDX | Sale | 20,900 | 35.06 | 732,858 |
| 2009-09-03 | GXDX | Option Ex | 12,519 | .38 | 4,757 |
| 2009-09-03 | GXDX | Sale | 12,519 | 30.03 | 375,958 |
| 2009-08-05 | GXDX | Option Ex | 15,259 | .38 | 5,798 |
| 2009-08-05 | GXDX | Sale | 15,259 | 30.34 | 463,003 |
| 2009-07-06 | GXDX | Option Ex | 9,259 | .38 | 3,518 |
| 2009-07-06 | GXDX | Sale | 9,259 | 27.50 | 254,603 |
| 2009-06-03 | GXDX | Sale | 9,259 | 29.64 | 274,399 |
| 2009-06-03 | GXDX | Option Ex | 9,259 | .38 | 3,518 |
| 2009-05-05 | GXDX | Sale | 9,259 | 28.37 | 262,696 |
| 2009-05-05 | GXDX | Option Ex | 9,259 | .38 | 3,518 |
| 2009-04-03 | GXDX | Sale | 9,259 | 29.01 | 268,603 |
| 2009-04-03 | GXDX | Option Ex | 9,259 | .38 | 3,518 |
| 2009-03-04 | GXDX | Option Ex | 9,259 | .38 | 3,518 |
| 2009-03-04 | GXDX | Sale | 9,259 | 27.83 | 257,715 |
| 2009-02-04 | GXDX | Sale | 18,518 | 33.74 | 624,871 |
| 2009-02-04 | GXDX | Option Ex | 18,518 | .38 | 7,036 |
| 2009-01-06 | GXDX | Sale | 18,518 | 31.97 | 592,057 |
| 2009-01-06 | GXDX | Option Ex | 18,518 | .81 | 14,999 |
| 2008-03-05 | GXDX | Sale | 118,212 | 25.50 | 3,014,406 |
| 2008-02-28 | GXDX | Option Ex | 117,542 | .81 | 95,209 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nova Tina Susan (Director of Arena Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.